» Articles » PMID: 24559811

Is Ginger Effective for the Treatment of Irritable Bowel Syndrome? A Double Blind Randomized Controlled Pilot Trial

Overview
Publisher Elsevier
Date 2014 Feb 25
PMID 24559811
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Ginger is one of the most commonly used herbal medicines for irritable bowel syndrome (IBS) but no data exists about its effectiveness.

Design: Double blind randomized controlled trial.

Setting: University of North Carolina, Chapel Hill, North Carolina, USA.

Intervention: Forty-five IBS patients were randomly assigned to three groups: placebo, 1g of ginger, and 2g of ginger daily for 28 days.

Main Outcome Measures: The IBS severity scale (IBS-SS) was administered, as well as adequate relief of symptoms scale. A responder was defined as having at least 25% reduction in IBS-SS post-treatment.

Results: There were 57.1% responders to placebo, 46.7% to 1g and 33.3% to 2g of ginger. Adequate relief was reported by 53.3% on placebo and 53.3% in both ginger groups combined. Side effects were mild and reported by 35.7% in the placebo and 16.7% in the ginger groups.

Conclusions: This double blind randomized controlled pilot study suggests ginger is well tolerated but did not perform better than placebo. Larger trials are needed before any definitive conclusions can be drawn.

Citing Articles

Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer's Disease.

Priyadarshini S, Goyal K, R R, Gupta S, Roy A, Biswas R Mol Neurobiol. 2025; .

PMID: 39982688 DOI: 10.1007/s12035-024-04484-y.


Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A "Real-World" Open-Label Study on 1585 Patients.

Ricci C, Saracino I, Valerii M, Spigarelli R, Bellocchio I, Spisni E Nutrients. 2025; 17(2).

PMID: 39861460 PMC: 11767699. DOI: 10.3390/nu17020328.


Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.

Huang K, Lv M, Zheng T, Wang F, Tang X, Lv L Front Pharmacol. 2024; 15:1475366.

PMID: 39669195 PMC: 11634590. DOI: 10.3389/fphar.2024.1475366.


6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk.

Zhao B, Ye J, Zhao W, Liu X, Lan H, Sun J Research (Wash D C). 2024; 7:0524.

PMID: 39512446 PMC: 11542252. DOI: 10.34133/research.0524.


Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights.

Salvatore S, Carlino M, Sestito S, Concolino D, Agosti M, Pensabene L Nutrients. 2024; 16(3).

PMID: 38337634 PMC: 10856962. DOI: 10.3390/nu16030349.


References
1.
Haniadka R, Rajeev A, Palatty P, Arora R, Baliga M . Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: a review. J Altern Complement Med. 2012; 18(5):440-4. DOI: 10.1089/acm.2010.0737. View

2.
Terry R, Posadzki P, Watson L, Ernst E . The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med. 2011; 12(12):1808-18. DOI: 10.1111/j.1526-4637.2011.01261.x. View

3.
Kaptchuk T, Friedlander E, Kelley J, Sanchez M, Kokkotou E, Singer J . Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2011; 5(12):e15591. PMC: 3008733. DOI: 10.1371/journal.pone.0015591. View

4.
van Tilburg M, Palsson O, Levy R, Feld A, Turner M, Drossman D . Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med. 2008; 8:46. PMC: 2499988. DOI: 10.1186/1472-6882-8-46. View

5.
Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C . The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol. 2006; 194(1):95-9. DOI: 10.1016/j.ajog.2005.06.046. View